Red Hat Keycloak Device Authorization Grant Flow improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.4 | $5k-$25k | 0.00+ |
Summary
A vulnerability, which was classified as critical, has been found in Red Hat Keycloak. The impacted element is an unknown function of the component Device Authorization Grant Flow. The manipulation leads to improper authorization. This vulnerability is traded as CVE-2026-88770. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability, which was classified as critical, has been found in Red Hat Keycloak (affected version unknown). This issue affects an unknown functionality of the component Device Authorization Grant Flow. The manipulation with an unknown input leads to a improper authorization vulnerability. Using CWE to declare the problem leads to CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
A flaw was found in the Device Authorization Grant flow of Keycloak, an identity and access management solution. The issue occurs because the token redemption process fails to check if a user account is currently locked due to brute-force protection. If an attacker has an active session for a locked account, they can complete the device login process and receive new security tokens. This allows the attacker to maintain access to the account even when it should be temporarily disabled to prevent unauthorized entry.
The advisory is shared at access.redhat.com. The identification of this vulnerability is CVE-2026-88770 since 09/10/2026. The exploitation is known to be easy. The attack may be initiated remotely. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 09/10/2026). MITRE ATT&CK project uses the attack technique T1548.002 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.redhat.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.4VulDB Meta Temp Score: 6.4
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector (redhat): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/10/2026 Advisory disclosed09/10/2026 CVE reserved
09/10/2026 VulDB entry created
09/10/2026 VulDB entry last update
Sources
Vendor: redhat.comAdvisory: access.redhat.com
Status: Not defined
CVE: CVE-2026-88770 (🔒)
GCVE (CVE): GCVE-0-2026-88770
GCVE (VulDB): GCVE-100-401969
Entry
Created: 09/10/2026 09:41Changes: 09/10/2026 09:41 (60)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.